Progesterone, inhibin, and hCG multiple marker strategy to differentiate viable from nonviable pregnancies

Maureen Glennon Phipps, Joseph W. Hogan, Jeffrey F. Peipert, Geralyn M. Lambert-Messerlian, Jacob A. Canick, David B. Seifer

Research output: Contribution to journalArticle

40 Scopus citations

Abstract

Objective: To determine whether a combination of serum and urine biomarkers drawn from symptomatic pregnant women will help early differentiation of viable from nonviable pregnancies. Methods: We conducted a prospective cohort study of 220 women who presented in the first trimester of pregnancy with complaints of pain, cramping, bleeding, or spotting. Serum samples for progesterone, inhibin A, and hCG, and urine beta-core hCG, were collected at presentation. To evaluate whether those biomarkers could predict viable and nonviable outcomes in pregnancy, we used likelihood ratios to compare operating characteristics of single and multiple biomarker strategies. Results: Of 220 pregnancies studied, 98 were viable and 122 nonviable. Among single biomarkers, progesterone alone appears to have the greatest utility (area under the receiver operator characteristic curve = 0.923). Among dual-biomarker strategies, progesterone plus hCG and progesterone plus inhibin A improved specificity but not sensitivity. At 95% sensitivity, the combination of progesterone and hCG improved specificity from 0.29 to 0.66 (improvement = 0.37 [95% confidence interval 0.23, 0.52]). A triple-biomarker combination did not show substantial improvement over the dual-biomarker strategy. Also, combinations that used urine beta-core hCG did not improve diagnostic accuracy.Conclusion: Serum progesterone appeared to be the single most specific biomarker for distinguishing viable from nonviable pregnancies. When a dual-biomarker strategy was applied, combining serum progesterone with hCG, specificity improved significantly, which suggests that a multiple biomarker strategy might help distinguish viable from nonviable pregnancies in early gestation. Copyright (C) 2000 The American College of Obstetricians and Gynecologists.

Original languageEnglish (US)
Pages (from-to)227-231
Number of pages5
JournalObstetrics and gynecology
Volume95
Issue number2
DOIs
StatePublished - Feb 1 2000

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Progesterone, inhibin, and hCG multiple marker strategy to differentiate viable from nonviable pregnancies'. Together they form a unique fingerprint.

  • Cite this

    Phipps, M. G., Hogan, J. W., Peipert, J. F., Lambert-Messerlian, G. M., Canick, J. A., & Seifer, D. B. (2000). Progesterone, inhibin, and hCG multiple marker strategy to differentiate viable from nonviable pregnancies. Obstetrics and gynecology, 95(2), 227-231. https://doi.org/10.1016/S0029-7844(99)00480-9